Psoriasis: Targets and Therapy (Jul 2022)

Biologics in Psoriasis: Updated Perspectives on Long-Term Safety and Risk Management [Corrigendum]

  • Al-Janabi A,
  • Yiu ZZN

Journal volume & issue
Vol. Volume 12
pp. 187 – 188

Abstract

Read online

Al-Janabi A, Yiu ZZN. Psoriasis (Auckl). 2022;12:1–14. The authors have advised that there is an error in Table 1 on page 2. The text “IL-7A” in the Target column for the Ixekizumab row should read “IL-17A”. The authors apologize for this error. Read the original article

Keywords